Marcos R. Gonzalez, Raylin F. Xu, Alisha Sodhi, Vincent Fang, Chaewon Kim, Tom M de Groot, Joseph H. Schwab, S. Lozano-Calderon
{"title":"使用碳纤维或钛植入物髓内钉治疗肿瘤性或病理性骨折后的患者报告结果","authors":"Marcos R. Gonzalez, Raylin F. Xu, Alisha Sodhi, Vincent Fang, Chaewon Kim, Tom M de Groot, Joseph H. Schwab, S. Lozano-Calderon","doi":"10.5435/JAAOSGlobal-D-23-00222","DOIUrl":null,"url":null,"abstract":"Introduction: Despite the benefits of intramedullary nailing (IMN) of impending or pathologic fractures in oncologic patients, literature on patient-reported outcomes (PROs) is scarce in patients treated with carbon fiber (CF) nails. Our study compared postoperative PROs after IMN with CF or titanium implants. Methods: We conducted a retrospective propensity score–matched cohort study of patients treated at our institution with CF or titanium nails for impending or pathologic fractures from metastatic bone disease. Patient-Reported Outcomes Measurement Information System (PROMIS) Global Health Short Form (SF) Physical, Mental, and Physical Function 10a scores were collected. Pain was assessed using visual analog scale (VAS). Absolute and differential scores were compared between groups. Results: We included 207 patients, 51 treated with CF and 156 with titanium nails. One month postoperatively, patients had a one-point decrease in the pain VAS score while PROMIS scores did not improve. At 3 months, PROMIS SF Physical and SF 10a scores improved from preoperative values. Six months postoperatively, median PROMIS SF Physical, SF Mental, and SF 10a scores were higher than preoperative scores. Absolute and differential PROMIS and pain VAS scores were similar between groups at the 6-month and 1-year marks. Conclusion: Patient-reported outcomes were similar after intramedullary nailing with either CF or titanium implants.","PeriodicalId":120051,"journal":{"name":"JAAOS: Global Research and Reviews","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Patient-Reported Outcomes After Intramedullary Nailing of Oncologic Impending or Pathologic Fractures With Carbon Fiber or Titanium Implant\",\"authors\":\"Marcos R. Gonzalez, Raylin F. Xu, Alisha Sodhi, Vincent Fang, Chaewon Kim, Tom M de Groot, Joseph H. Schwab, S. Lozano-Calderon\",\"doi\":\"10.5435/JAAOSGlobal-D-23-00222\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Introduction: Despite the benefits of intramedullary nailing (IMN) of impending or pathologic fractures in oncologic patients, literature on patient-reported outcomes (PROs) is scarce in patients treated with carbon fiber (CF) nails. Our study compared postoperative PROs after IMN with CF or titanium implants. Methods: We conducted a retrospective propensity score–matched cohort study of patients treated at our institution with CF or titanium nails for impending or pathologic fractures from metastatic bone disease. Patient-Reported Outcomes Measurement Information System (PROMIS) Global Health Short Form (SF) Physical, Mental, and Physical Function 10a scores were collected. Pain was assessed using visual analog scale (VAS). Absolute and differential scores were compared between groups. Results: We included 207 patients, 51 treated with CF and 156 with titanium nails. One month postoperatively, patients had a one-point decrease in the pain VAS score while PROMIS scores did not improve. At 3 months, PROMIS SF Physical and SF 10a scores improved from preoperative values. Six months postoperatively, median PROMIS SF Physical, SF Mental, and SF 10a scores were higher than preoperative scores. Absolute and differential PROMIS and pain VAS scores were similar between groups at the 6-month and 1-year marks. Conclusion: Patient-reported outcomes were similar after intramedullary nailing with either CF or titanium implants.\",\"PeriodicalId\":120051,\"journal\":{\"name\":\"JAAOS: Global Research and Reviews\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JAAOS: Global Research and Reviews\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5435/JAAOSGlobal-D-23-00222\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JAAOS: Global Research and Reviews","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5435/JAAOSGlobal-D-23-00222","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
简介:尽管髓内钉(IMN)可治疗肿瘤患者即将发生的骨折或病理性骨折,但使用碳纤维(CF)钉治疗患者的患者报告结果(PROs)方面的文献却很少。我们的研究比较了使用碳纤维髓内钉或钛植入物进行髓内钉治疗后的术后观察结果。方法:我们对在本院接受碳纤维钉或钛钉治疗的转移性骨病即将发生骨折或病理性骨折的患者进行了倾向得分匹配队列回顾性研究。我们收集了患者报告结果测量信息系统(PROMIS)全球健康简表(SF)的身体、精神和身体功能 10a 评分。疼痛采用视觉模拟量表(VAS)进行评估。比较各组的绝对得分和差异得分。结果我们共纳入了 207 名患者,其中 51 人接受了 CF 治疗,156 人接受了钛钉治疗。术后一个月,患者的疼痛 VAS 评分下降了一分,而 PROMIS 评分没有改善。3 个月后,PROMIS SF 物理评分和 SF 10a 评分比术前有所提高。术后 6 个月,PROMIS SF 体力评分、SF 精神评分和 SF 10a 评分的中位数均高于术前评分。在 6 个月和 1 年时,各组的 PROMIS 和疼痛 VAS 绝对评分和差异评分相似。结论使用CF或钛植入物进行髓内钉治疗后,患者报告的结果相似。
Patient-Reported Outcomes After Intramedullary Nailing of Oncologic Impending or Pathologic Fractures With Carbon Fiber or Titanium Implant
Introduction: Despite the benefits of intramedullary nailing (IMN) of impending or pathologic fractures in oncologic patients, literature on patient-reported outcomes (PROs) is scarce in patients treated with carbon fiber (CF) nails. Our study compared postoperative PROs after IMN with CF or titanium implants. Methods: We conducted a retrospective propensity score–matched cohort study of patients treated at our institution with CF or titanium nails for impending or pathologic fractures from metastatic bone disease. Patient-Reported Outcomes Measurement Information System (PROMIS) Global Health Short Form (SF) Physical, Mental, and Physical Function 10a scores were collected. Pain was assessed using visual analog scale (VAS). Absolute and differential scores were compared between groups. Results: We included 207 patients, 51 treated with CF and 156 with titanium nails. One month postoperatively, patients had a one-point decrease in the pain VAS score while PROMIS scores did not improve. At 3 months, PROMIS SF Physical and SF 10a scores improved from preoperative values. Six months postoperatively, median PROMIS SF Physical, SF Mental, and SF 10a scores were higher than preoperative scores. Absolute and differential PROMIS and pain VAS scores were similar between groups at the 6-month and 1-year marks. Conclusion: Patient-reported outcomes were similar after intramedullary nailing with either CF or titanium implants.